| The DNA methylome and transcriptome of different brain regions in schizophrenia and bipolar disorder Y Xiao, C Camarillo, Y Ping, TB Arana, H Zhao, PM Thompson, C Xu, ... PloS one 9 (4), e95875, 2014 | 105 | 2014 |
| Identification of cancer-related lncRNAs through integrating genome, regulome and transcriptome features T Zhao, J Xu, L Liu, J Bai, C Xu, Y Xiao, X Li, L Zhang Molecular BioSystems 11 (1), 126-136, 2015 | 100 | 2015 |
| A comparison for dimensionality reduction methods of single-cell RNA-seq data R Xiang, W Wang, L Yang, S Wang, C Xu, X Chen Frontiers in genetics 12, 646936, 2021 | 99 | 2021 |
| Identification of a five‐lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer J Li, W Wang, P Xia, L Wan, L Zhang, L Yu, L Wang, X Chen, Y Xiao, C Xu International journal of cancer 143 (9), 2150-2160, 2018 | 73 | 2018 |
| Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles C Xu, Y Ping, X Li, H Zhao, L Wang, H Fan, Y Xiao, X Li Molecular biosystems 10 (11), 2800-2809, 2014 | 66 | 2014 |
| Systematically characterizing dysfunctional long intergenic non-coding RNAs in multiple brain regions of major psychosis J Hu, J Xu, L Pang, H Zhao, F Li, Y Deng, L Liu, Y Lan, X Zhang, T Zhao, ... Oncotarget 7 (44), 71087, 2016 | 41 | 2016 |
| Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data Y Ping, Y Deng, L Wang, H Zhang, Y Zhang, C Xu, H Zhao, H Fan, F Yu, ... Nucleic acids research 43 (4), 1997-2007, 2015 | 41 | 2015 |
| Discovering dysfunction of multiple microRNAs cooperation in disease by a conserved microRNA co-expression network Y Xiao, C Xu, J Guan, Y Ping, H Fan, Y Li, H Zhao, X Li PloS one 7 (2), e32201, 2012 | 40 | 2012 |
| Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes L Wang, J Li, H Zhao, J Hu, Y Ping, F Li, Y Lan, C Xu, Y Xiao, X Li Molecular BioSystems 12 (3), 711-720, 2016 | 33 | 2016 |
| Prioritizing cancer-related key miRNA–target interactions by integrative genomics Y Xiao, J Guan, Y Ping, C Xu, T Huang, H Zhao, H Fan, Y Li, Y Lv, T Zhao, ... Nucleic acids research 40 (16), 7653-7665, 2012 | 31 | 2012 |
| Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer Q Meng, S Wang, S Zhou, H Liu, X Ma, X Zhou, H Liu, C Xu, W Jiang The pharmacogenomics journal 20 (2), 227-234, 2020 | 29 | 2020 |
| Cooperative genomic alteration network reveals molecular classification across 12 major cancer types H Zhang, Y Deng, Y Zhang, Y Ping, H Zhao, L Pang, X Zhang, L Wang, ... Nucleic acids research 45 (2), 567-582, 2017 | 24 | 2017 |
| Identifying dysfunctional miRNA-mRNA regulatory modules by inverse activation, cofunction, and high interconnection of target genes: a case study of glioblastoma Y Xiao, Y Ping, H Fan, C Xu, J Guan, H Zhao, Y Li, Y Lv, Y Jin, L Wang, ... Neuro-oncology 15 (7), 818-828, 2013 | 24 | 2013 |
| LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions C Xu, Y Ping, H Zhao, S Ning, P Xia, W Wang, L Wan, J Li, L Zhang, L Yu, ... Oncotarget 8 (70), 114603, 2017 | 23 | 2017 |
| Systematical identification of breast cancer-related circular RNA modules for deciphering circRNA functions based on the non-negative matrix factorization algorithm S Wang, P Xia, L Zhang, L Yu, H Liu, Q Meng, S Liu, J Li, Q Song, J Wu, ... International Journal of Molecular Sciences 20 (4), 919, 2019 | 19 | 2019 |
| Differential expression pattern-based prioritization of candidate genes through integrating disease-specific expression data Y Xiao, C Xu, Y Ping, J Guan, H Fan, Y Li, X Li Genomics 98 (1), 64-71, 2011 | 18 | 2011 |
| Dissecting the functional mechanisms of somatic copy-number alterations based on dysregulated ceRNA networks across cancers Y Ping, Y Zhou, J Hu, L Pang, C Xu, Y Xiao Molecular Therapy-Nucleic Acids 21, 464-479, 2020 | 14 | 2020 |
| Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations C Xu, R Qi, Y Ping, J Li, H Zhao, L Wang, MY Du, Y Xiao, X Li Oncotarget 8 (7), 12041, 2017 | 14 | 2017 |
| Identification and functional analysis of specific MS risk miRNAs and their target genes D Luo, J Wang, X Zhang, X Rang, C Xu, J Fu Multiple Sclerosis and Related Disorders 41, 102044, 2020 | 12 | 2020 |
| IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals Y Ping, H Zhang, Y Deng, L Wang, H Zhao, L Pang, H Fan, C Xu, F Li, ... Molecular BioSystems 10 (8), 2031-2042, 2014 | 12 | 2014 |
